Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
Work
Year: 2024
Type: article
Source: Blood
Institutions The University of Sydney, King's College London, Guy's and St Thomas' NHS Foundation Trust, Monash University, University of Birmingham +10 more
Cites: 22
Cited by: 28
Related to: 10
FWCI: 46.41
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed